By Iain Gilbert
Date: Thursday 06 Feb 2025
(Sharecast News) - Shares in pharmaceutical giant Bristol Myers Squibb headed south in early trading as its solid Q4 revenue performance was offset by FY25 guidance that fell short of Wall Street expectations.
| Currency | US Dollars |
| Share Price | $ 55.92 |
| Change Today | $ 0.15 |
| % Change | 0.27 % |
| 52 Week High | $63.11 |
| 52 Week Low | $42.60 |
| Volume | 10,924,237 |
| Shares Issued | 2,006.00m |
| Market Cap | $112,176m |
| Beta | 0.45 |
| RiskGrade | 106 |
| Time | Volume / Share Price |
| 15:59 | 161 @ $55.94 |
| 15:59 | 198 @ $55.94 |
| 15:59 | 412 @ $55.94 |
| 15:59 | 100 @ $55.94 |
| 15:59 | 100 @ $55.94 |
You are here: research